Public Employees Retirement Association of Colorado lowered its stake in shares of UiPath Inc. (NYSE:PATH – Free Report) by 3.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 44,023 shares of the healthcare company’s stock after selling 1,692 shares during the period. Public Employees Retirement Association of Colorado’s holdings in UiPath were worth $558,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of UiPath by 5.6% during the 1st quarter. Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company’s stock worth $911,741,000 after purchasing an additional 2,133,078 shares during the period. State Board of Administration of Florida Retirement System increased its position in shares of UiPath by 0.5% in the first quarter. State Board of Administration of Florida Retirement System now owns 295,370 shares of the healthcare company’s stock worth $6,696,000 after acquiring an additional 1,571 shares in the last quarter. Mitsubishi UFJ Trust & Banking Corp raised its stake in shares of UiPath by 4.2% in the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 231,694 shares of the healthcare company’s stock valued at $5,240,000 after acquiring an additional 9,393 shares during the period. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of UiPath by 3,389.4% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 89,189 shares of the healthcare company’s stock valued at $1,131,000 after acquiring an additional 86,633 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its position in UiPath by 245.1% during the 1st quarter. Acadian Asset Management LLC now owns 45,700 shares of the healthcare company’s stock worth $1,032,000 after purchasing an additional 32,456 shares during the period. Institutional investors and hedge funds own 62.50% of the company’s stock.
Insider Buying and Selling
In other UiPath news, CFO Ashim Gupta sold 47,671 shares of the business’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $12.07, for a total transaction of $575,388.97. Following the completion of the transaction, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at approximately $10,258,498.19. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 22.37% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Analysis on PATH
UiPath Stock Performance
UiPath stock opened at $12.58 on Friday. The company has a market cap of $7.21 billion, a P/E ratio of -78.63 and a beta of 0.87. UiPath Inc. has a 1 year low of $10.37 and a 1 year high of $27.87. The firm’s 50-day moving average is $12.14 and its 200-day moving average is $15.64.
UiPath (NYSE:PATH – Get Free Report) last issued its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. The firm had revenue of $316.00 million during the quarter, compared to the consensus estimate of $303.69 million. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The firm’s revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the business earned ($0.09) EPS. As a group, sell-side analysts predict that UiPath Inc. will post -0.23 earnings per share for the current year.
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories
- Five stocks we like better than UiPath
- How to Use the MarketBeat Excel Dividend Calculator
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.